-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Edesa Biotech, Inc. annual and quarterly Amortization of Intangible Assets in USD history and change rate from 31 Aug 2012 to 30 Sep 2025.
- Edesa Biotech, Inc. Amortization of Intangible Assets for the quarter ending 30 Jun 2025 was $30,000, unchanged year-over-year.
- Edesa Biotech, Inc. annual Amortization of Intangible Assets for 2025 was $101,172,000,000.
- Edesa Biotech, Inc. annual Amortization of Intangible Assets for 2024 was $101,172,000,000.
- Edesa Biotech, Inc. annual Amortization of Intangible Assets for 2023 was $101,172,000,000.